Gastric cancer (GC) results from deregulated cell growth in the stomach. Despite significant
efforts and recent advancements in the treatment of gastric cancer, it remains a life …

Gastric cancer is one of the most common malignant tumors, and it is also one of the leading
causes of cancer death worldwide. Because of its insidious symptoms and lack of early …

In this study, we aimed to investigate the effects of curcumin on cell activities of gastric
cancer (GC), and the connection between curcumin and P53, as well as, PI3K signaling …

The principle factors underlying gastric cancer (GC) development and outcomes are not well
characterized resulting in a paucity of validated therapeutic targets. To identify potential …

Background Recently, molecular classifications of gastric cancer (GC) have been proposed
that include TP53 mutations and their functional activity. We aimed to demonstrate the …

Gastric cancers (GCs) are among the most common and fatal malignancies in the world.
Despite our increasing understanding of the molecular mechanisms underlying GC, further …

Gastric cancer (GC) is one of the most frequent malignancies worldwide. Long noncoding
RNAs (lncRNAs) are found to be largely implicated in various cancers, including GC …

Gastric cancer (GC) is a heterogeneous disease, often diagnosed at advanced stages, with
a 5-year survival rate of approximately 20%. Despite notable technological advancements in …

Helicobacter pylori (H. pylori) is well-known to be involved in gastric carcinogenesis,
associated with deregulation of cell proliferation and epigenetic changes in cancer-related …

Familial clustering is seen in 10% of gastric cancer cases and approximately 1–3% of gastric
cancer arises in the setting of hereditary diffuse gastric cancer (HDGC). In families with …